News Archive
Until now, understanding and using genetic information has depended on the scientists and doctors who do the testing. No longer.
Stryker Corporation announced today the closing of its previously announced acquisition of the assets of the Neurovascular division of Boston Scientific, the global leader in the approximately $900 million worldwide neurovascular market, which includes products used for the minimally invasive treatment of hemorrhagic and ischemic stroke.
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.
A recent analysis of published studies examined the clinical consequences of medication adherence. The British Journal of Clinical Pharmacology analysis found that medication adherence is linked with lower risks of needing to be hospitalized and of dying early.
New emergency care guidelines simplify performing cardiopulmonary resuscitation (CPR) and highlight the need for high quality CPR by addressing some of the barriers to performing CPR. The Heart and Stroke Foundation of Canada, co-author of the 2010 Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC), released the guidelines today.
› Verified 5 days ago